Ophthalmic surgery, lasers & imaging retina · 2020 · 35 citations · 13 references
MedicineOphthalmologyVision ScienceOcular DiseaseOphthalmic SurgeryVisual DisordersAge-related Macular DegenerationDiabetic RetinopathyMacular DegenerationMacular DiseaseMacular DisordersVisual ImpairmentAge-related BlindnessCauses Of BlindnessDiabetic Retinopathy BlindnessDirect CostsOcular Disease Burden EstimationQuality-adjusted Life Year PerspectiveSocial Cost AssessmentVision Impairment Burden
BACKGROUND AND OBJECTIVE: To estimate the social cost of blindness due to wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and proliferative diabetic retinopathy (PDR) in the United States in 2020. PATIENTS AND METHODS: Excess costs that occur because of blindness were estimated as the difference in costs in blind versus non-blind individuals. Per-patient costs were aggregated using the number of cases of blindness due to wAMD, DME, and PDR projected in 2020. RESULTS: Associated annual excess direct costs, indirect costs, and quality-adjusted life year loss per blind individual were $4,944, $54,614, and 0.214, respectively. Combining estimates with 246,423 projected cases of blindness due to wAMD, DME, and PDR translated to total societal costs of $20 billion in 2020, estimated to triple by 2050. CONCLUSION: Excess social costs associated with blindness in individuals with wAMD, DME, and PDR are substantial, with more than half of the burden attributed to indirect costs. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:S6-S14.].
13
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
Archives of Ophthalmology · 2004 · 2.6K citations · Full text
Medicine, Demography, Ophthalmology +17
Sobha Sivaprasad, A Toby Prevost, Joana C. Vasconcelos et al. · The Lancet · 2017 · 387 citations · Full text